Analysis of gene expression profiles derived from human induced pluripotent stem cell-derived neuronal cultures, primary cortical neurons, and glial cells exposed to various stressors, including oxygen-glucose deprivation and amyloid-beta oligomers, revealed significant alterations in the expression of genes associated with synaptic plasticity, neuroinflammation, and apoptosis, suggesting a complex interplay between cellular stress responses and the pathogenesis of neurodegenerative diseases, with specific emphasis on the differential regulation of genes encoding synaptic proteins, such as synaptophysin and PSD-95, as well as pro-inflammatory cytokines, including IL-1β and TNF-α, which could serve as potential therapeutic targets for mitigating neuronal damage and promoting neuroprotection in the context of neurological disorders.

Comparative transcriptomic analysis of postmortem brain tissue samples from individuals diagnosed with Alzheimer's disease, Parkinson's disease, and age-matched controls, utilizing RNA sequencing and microarray technologies, identified distinct gene expression signatures characteristic of each neurodegenerative condition, highlighting the dysregulation of genes involved in various cellular processes, including mitochondrial function, oxidative stress, protein aggregation, and neurotransmitter signaling, providing insights into the molecular mechanisms underlying these diseases and paving the way for the development of novel diagnostic and therapeutic strategies targeting the identified differentially expressed genes, such as those related to amyloid precursor protein processing, alpha-synuclein aggregation, and dopamine metabolism.

Investigation of gene expression changes in mouse models of Huntington's disease, utilizing striatal tissue from transgenic mice expressing mutant huntingtin protein and wild-type littermates, revealed a progressive decline in the expression of genes involved in neuronal survival, synaptic function, and transcriptional regulation, accompanied by an increase in the expression of genes associated with inflammation and apoptosis, suggesting a complex cascade of molecular events leading to neuronal dysfunction and degeneration, with potential therapeutic implications for targeting the dysregulated pathways, including the modulation of huntingtin protein aggregation, the enhancement of neurotrophic factor signaling, and the suppression of neuroinflammatory processes.

Gene expression profiling of glioblastoma multiforme, the most aggressive primary brain tumor, using patient-derived tumor samples and established glioblastoma cell lines, identified specific gene expression patterns associated with tumor grade, prognosis, and response to therapy, highlighting the upregulation of genes involved in cell proliferation, angiogenesis, and invasion, as well as the downregulation of genes involved in cell cycle regulation and apoptosis, providing valuable insights into the molecular mechanisms driving glioblastoma pathogenesis and informing the development of targeted therapies aimed at inhibiting oncogenic pathways and promoting tumor cell death, such as those involving growth factor receptors, cell cycle checkpoints, and apoptotic regulators.

Transcriptomic analysis of human brain organoids, three-dimensional in vitro models of human brain development, derived from induced pluripotent stem cells, revealed spatiotemporal changes in gene expression patterns mirroring key stages of human brain development, including neurogenesis, neuronal differentiation, and synaptogenesis, providing a powerful platform for studying the molecular mechanisms underlying human brain development and disease, and enabling the investigation of the effects of genetic mutations and environmental factors on neuronal differentiation and function, with potential applications in drug discovery and personalized medicine.

Examination of gene expression profiles in different brain regions, including the prefrontal cortex, hippocampus, and cerebellum, from healthy individuals and patients with psychiatric disorders, such as schizophrenia and major depressive disorder, revealed region-specific alterations in the expression of genes involved in neurotransmitter signaling, synaptic plasticity, and immune function, suggesting a complex interplay between genetic predisposition, environmental factors, and brain region-specific vulnerability in the pathogenesis of these disorders, with potential implications for the development of novel therapeutic strategies targeting the dysregulated pathways and brain regions.

Single-cell RNA sequencing of human brain tissue samples revealed remarkable cellular heterogeneity within the brain, identifying distinct gene expression profiles for various neuronal and glial cell types, including excitatory neurons, inhibitory neurons, astrocytes, oligodendrocytes, and microglia, providing unprecedented insights into the cellular architecture and functional organization of the human brain and enabling the investigation of cell-type specific contributions to neurological diseases, with potential applications in developing targeted therapies for specific cell populations affected by these disorders.

Analysis of gene expression data from rodent models of stroke, including both ischemic and hemorrhagic stroke, revealed dynamic changes in gene expression patterns in the affected brain regions, highlighting the upregulation of genes involved in inflammation, apoptosis, and oxidative stress, as well as the downregulation of genes involved in neuronal function and synaptic plasticity, providing insights into the molecular mechanisms underlying neuronal damage and recovery following stroke and suggesting potential therapeutic targets for neuroprotection and stroke rehabilitation.

Investigation of gene expression profiles in brain tissue samples from individuals with epilepsy, utilizing both surgical resections and postmortem tissue, revealed alterations in the expression of genes involved in neuronal excitability, synaptic transmission, and ion channel function, suggesting a complex interplay between genetic and environmental factors in the development of epilepsy, with potential implications for the development of novel antiepileptic drugs targeting the dysregulated pathways, including those involved in GABAergic and glutamatergic neurotransmission.

Comparative gene expression analysis of brain tissue samples from different primate species, including humans, chimpanzees, and macaques, revealed evolutionary changes in the expression of genes involved in brain development, cognition, and social behavior, providing insights into the genetic basis of human brain evolution and highlighting the role of gene regulatory mechanisms in shaping the unique features of the human brain, including its increased size, complexity, and cognitive abilities.
